VIP Peptide: Possible Impacts on Inflammation

The intestinal cells release VIP, also known as a vasoactive intestinal peptide, a 28-amino acid peptide. Studies suggest that VIP may have a variety of medical research uses. A growing amount of data suggests that the VIP peptide may be useful in the context of neurodegenerative diseases and for reducing inflammation in other parts of the organism.

According to experts, vasoactive intestinal polypeptide (VIP) seems to protect the central nervous system against harmful activities as an immune system regulator. As neurodegenerative illness progresses, researchers want to know whether VIP may help retain cognitive function in healthy research models.

Studies have suggested that several gastrointestinal hormones may work as neurotransmitters in the brain, even though this role has not been fully understood. Glucagon, motilin, somatostatin, and neuropeptide Y are only a few hormones that have been hypothesized to play a role in the organism's response to stress.

Biotech Peptides is the place to go if you need VIP peptides for your study. Read on to discover more about VIP's mechanism of action, its impact on the organism, its possible properties, and where you can find VIP peptides for sale.

What is the Vasoactive Intestinal Peptide (VIP)?

VIP is a glucagon superfamily member found in vertebrates' stomachs, brains, and pancreas. This peptide has been hypothesized to stimulate the heart, enhance glycogenolysis, generate vasodilation, decrease blood pressure, and soothe the gallbladder and stomach muscles. VIP hormone has also been suggested to boost pancreatic juice, water, and bile production for decades.

VIP Peptide: Properties

  • Digestive system—Studies suggest that VIP peptide may relax smooth muscles, increase water secretion from the pancreas, and reduce gastric acid release and retention from the intestinal lumen in the digestive tract. It has been hypothesized that Colitis and Crohn's disease may also profit from the peptide.
  • Heart—Research indicates that precursor peptide VIP may influence the heart. It is believed to have a favorable inotropic and chronotropic impact on the coronary arteries and stimulate coronary vasodilation.
  • Brain- Investigations purport that prolactin and growth hormone production in the pituitary gland may be regulated and stimulated by the brain.

VIP Peptide and Nerves

Findings imply that neurotransmitter, neurotrophic/neurogenic, and anti-inflammatory/neuroprotective actions may all be part of VIP's central nervous system activity. Its trip starts with the organism's defenses in place. The health of the blood-brain barrier is essential for regulating the flow of nutrients, immune cells, and oxygen to the brain's tissue. Stroke, MS, and encephalomyelitis are just a few health problems that might arise if this system is disrupted.

Using mice with Alzheimer's disease, researchers suggested that VIP peptide hormone may also control beta-amyloid buildup. Scientists think it might have powerful neuroprotective properties in Parkinson's disease and other associated disorders.

New findings suggest that gastrointestinal peptide (VIP) may be an important neuroprotectant in the brain. Scientists speculate that it may protect it from white matter injury and boost neuron function. It has been hypothesized that VIP may also have anti-inflammatory properties in the context of Parkinson's disease.

A definitive study suggesting VIP involvement in AD does not exist now. Peptide levels in Alzheimer's disease research models seem to be lower, suggesting that it might be used as an agent or prophylactic. After all, research postulates that giving VIP to mice may reduce beta-amyloid levels significantly, suggesting the peptide's potential to have a favorable influence on Alzheimer's disease.


Cardiac Fibrosis

Several heart diseases lead to a condition known as cardiac fibrosis. As a result, the heart's valves become dysfunctional, its filling is altered, and its contractility is reduced. When fibrosis develops in the lungs, it often necessitates a transplant.

There is now a lot of attention paid to producing scars in the heart, and several compounds may halt the remodeling process that leads to scarring. It's a shame that success rates are so poor, with research models suffering from increasing fibrosis and heart failure.

Recent rat research has ascertained that VIP peptide may reduce fibrosis and reverse scarring. Researchers think a significant decrease in angiotensinogen and angiotensin receptor 1a expression is responsible.